Skip to main content
Log in

Consistency of assessment of adverse drug reactions in psychiatric hospitals: A comparison of an algorithmic and an empirical approach

  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Within an ongoing drug surveillance project (AMÜP) in psychiatric hospitals, a comparative study was carried out to evaluate two methods commonly used in the field of adverse drug reaction assessment. Two raters, who have cooperated with the project since its inception, evaluated 80 randomly selected ADRs twice; first, by an empirical (implicit) approach, and second, 4 weeks later, by using an algorithm as proposed by Kramer et al. 1979. Agreement on medication and related probability ratings was obtained in 81% of all 80 cases for the empirical method (weighted Kappa=0.41), and in 69% for the algorithmic method (weighted Kappa=0.62), indicating that agreement exceeded chance for both methods. By comparison with assessments made in previous case conferences of the project, empirical ratings were found to be reliable over time due to homogeneous use of criteria by project raters. In contrast to the reports on the subject, agreement between raters appeared to be superior in the empirical method as compared to the algorithmic assessment. Analysis of disagreements suggested that probability ratings based on the empirical method were nonspecific, due to conventional criteria applied in the project. Inter-rater agreement was reduced by polypharmacy, especially in the case of algorithmic assessments. The consistency of assessment was also lowered by the fact that the 2 methods assigned different weights to particular assessment criteria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ruether E, Benkert O, Eckmann F, Eckmann J, Grohmann R, Helmchen H, Hippius H, Müller-Oerlinghausen B, Poser W, Schmidt LG, Stille G, Strauss A, Überla K (1980) Drug Monitoring in psychiatrischen Kliniken. Arzneimittelforsch/Drug Res 30 (II): 1181–1183

    Google Scholar 

  2. Grohmann R, Hippius H, Müller-Oerlinghausen B, Rüther E, Scherer J, Schmidt LG, Strauss A, Wolf B (1984) Assessment of adverse drug reactions in psychiatric hospitals. Eur J Clin Pharmacol 26: 727–734

    Google Scholar 

  3. Schmidt LG, Grohmann R, Helmchen H, Langscheid-Schmidt K, Müller-Oerlinghausen B, Poser W, Rüther E, Scherer J, Strauss A, Wolf B (1984) Adverse drug reactions — an epidemiological study at psychiatric hospitals. Acta Psychiatr Scand 70: 77–89

    Google Scholar 

  4. Venulet J (1982) Assessing causes of adverse drug reactions with special reference to standardized methods. Academic Press, London

    Google Scholar 

  5. Karch FE, Smith CL, Kerzner B, Mazullo M, Weintraub M, Lasagna L (1976) Adverse drug reactions — a matter of opinion. Clin Pharmacol Ther 19: 489–492

    Google Scholar 

  6. Karch FE, Lasagna L (1977) Towards the operational identification of adverse drug reactions. Clin Pharmacol Ther 21: 247–254

    Google Scholar 

  7. Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR (1979) An algorithm for the operational assessment of adverse drug reactions. I. Background, description and instruction for use. J Am Med Assoc 242: 623–632

    Google Scholar 

  8. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janacek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30: 239–245

    Google Scholar 

  9. Karch FE, Lasagna L (1975) Adverse drug reactions. J Am Med Assoc 234: 1236–1241

    Google Scholar 

  10. Seidl LG, Thornton GF, Cluff LE (1965) Epidemiological studies of adverse drug reactions. Am J Public Health 55: 1170–1175

    Google Scholar 

  11. Hurwitz N, Wade OL (1969) Intensive hospital monitoring of adverse reactions to drugs. Br Med J 1: 531–536

    Google Scholar 

  12. Martindale W (1982) The extra pharmacopoeia (28th edn) Pharmaceutical Press, London

    Google Scholar 

  13. Cohen J (1968) Weighted Kappa: Nominal scale agreement with provision for scaled disagreement of partial credit. Psychol Bull 70: 213–220

    Google Scholar 

  14. Kramer MS, Feinstein AR (1981) Clinical biostatics. LIV. The biostatics of concordance. Clin Pharmacol Ther 29: 111–123

    Google Scholar 

  15. Hutchinson TA, Leventhal JM, Kramer MS, Karch FE, Lipman AG, Feinstein AR (1979) An algoritm for the operational assessment of adverse drug reactions. II. Demonstration of reproducibility and validity. J Am Med Assoc 242: 633–638

    Google Scholar 

  16. Leventhal JM, Hutchinson TA, Kramer MS, Feinstein AR (1979) An algorithm for the operational assessment of adverse drug reactions. III. Results of test among clinicians. J Am Med Assoc 242: 1991–1994

    Google Scholar 

  17. Blanc S, Leuenberger P, Berger JM, Brooke EM, Schelling JL (1979) Judgment of trained observers on adverse drug reactions. Clin Pharmacol Ther 25: 493–498

    Google Scholar 

  18. Hutchinson TA, Flegel KM, Hopingkong H, Bloom WS, Kramer MS, Trummer EG (1983) Reasons for disagreement in the standardized assessment of suspected adverse drug reactions. Clin Pharmacol Ther 34: 421–426

    Google Scholar 

  19. Grohmann R, Dirschedl P, Scherer J, Schmidt LG, Wunderlich O (1985) Reliability of adverse drug reaction assessment in psychiatric in-patients. Eur Arch Psychiatr Neurol Sci 235: 158–163

    Google Scholar 

  20. Begaud B, Boisseau A, Dangoumau J (1981) Comparaison de quatre méthodes d'imputabilité des effets indésirables des médicaments. Thérapie 36: 65–70

    Google Scholar 

  21. Pere JC, Begaud B, Haramburu F, Albin H (1984) Méthodes d'étude des effets indésirables des médicamentes. II. Profil et comparaison de cinq méthodes d'imputabilité. Thérapie 39: 369–378

    Google Scholar 

  22. Miller RR, Greenblatt DJ (eds), (1976) Drug effects in hospitalized patients. Experiences of the Boston Collaborative Drug Surveillance Program 1966–1975. Wiley & Sons, New York

    Google Scholar 

  23. Koch-Weser J, Sellers EM, Zacest R (1977) The ambiguity of adverse drug reactions. Eur J Clin Pharmacol 11: 75–78

    Google Scholar 

  24. Grohmann R, Strauss A, Gehr C, Rüther E, Hippius H (1980) Zur Praxis der Klinischen Therapie mit Psychopharmaka. Pharmacopsychiatry 13: 1–19

    Google Scholar 

  25. Schmidt LG, Niemeyer R, Müller-Oerlinghausen B (1983) Drug prescribing pattern of a psychiatric university hospital in Germany. Pharmacopsychiatry 16: 35–42

    Google Scholar 

  26. Kewitz H (1977) Erhebungen über die Arzneitherapie in der Klinik. Verh Dtsch Ges Inn Med 83: 1487–1502

    Google Scholar 

  27. Weber E, Hollmann M (eds), (1981) Drug utilization studies in hospitals. Schattauer, Stuttgart New York

    Google Scholar 

  28. Louik C, Lacouture PG, Mitchell AA, Kaufmann R, Lovejoy FH, Summer SJ, Shapiro S (1985): A study of adverse reaction algorithms in a drug surveillance program. Clin Pharmacol Ther 38: 183–187

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Dedicated to Prof. Dr. H. Kewitz, Head of the Department of Clinical Pharmacology, Klinikum Steglitz, Berlin (West), on the occasion of his 65th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmidt, L.G., Dirschedl, P., Grohmann, R. et al. Consistency of assessment of adverse drug reactions in psychiatric hospitals: A comparison of an algorithmic and an empirical approach. Eur J Clin Pharmacol 30, 199–204 (1986). https://doi.org/10.1007/BF00614303

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00614303

Key words

Navigation